한독
8,520KRWMarket close of 10/21 (Wed)
Up +0.12%+10KRWMarket close of 10/21 (Wed)
- Open
- 8,510
- High
- 8,760
- Low
- 8,510
- Day range
- Day range low 8,510 high 8,760, open 8,510, close 8,520, previous close 8,510
- Volume
- 0×10K shares
- 25.47 million KRW 0.43× the 20-session average
Market close of 10/21 (Wed)
Where it sits in the 1-year range
34%1-year close range 6,700 to 12,070 won, 34% up from the low
34% of the way up from the lowest close in 1 year (252 sessions) · -29.4% from the high
Usual range
Nothing unusual in the 4 checked items
Free · no sign-inSource from 2021-05-17
Points to check
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
- Daily moveusual range+0.12%+0.12%, 0.1× the usual (20-session average ±1.63%)That day +0.12% · usual ±1.63% · large-move threshold ±3.3%
The other 3 are within the usual range
- Trading value0.4×usual range
- EarningsOperating income, 8 quarters
- Data date10/21 (Wed)Market close
See the full check report
Quarterly results · Q1 2026
- Revenue135.4B KRW
- vs. year ago
- +13.0%
- vs. prior quarter
- -3.3%
- Operating income753.23 million KRW
- vs. year ago
- Turned profitable
- vs. prior quarter
- -83.4%
- Operating margin0.6%
- vs. year ago
- +1.9 pp
- vs. prior quarter
- -2.7 pp
Quarterly operating income trend
As of the latest official close · 2026-10-21Valuation filing date · 2026-05-14Same sector · 제약
Up +0.83%· 57 of 168 stocks up, preferred shares excluded · trading value 730.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 삼성바이오로직스 | Close over the last 20 sessions +1.5% | Up +1.87% | 166.1B KRW |
| 셀트리온 | Close over the last 20 sessions +9.6% | Up +0.10% | 119.2B KRW |
| 지투지바이오 | Close over the last 20 sessions +27.6% | Up +13.78% | 49.8B KRW |
| 삼익제약 | Close over the last 20 sessions -20.3% | Up +2.58% | 47.2B KRW |
| 유한양행 | Close over the last 20 sessions +11.7% | Up +0.46% | 35.3B KRW |
Schedule
- Next data 10/23 (Fri) after 08:50
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.